Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes

Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer

(2010) Chad J. Creighton et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Symplekin promotes tumorigenicity by up-regulating claudin-2 expression

(2010) M. Buchert et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

(2010) J. H. Taube et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

(2009) B. T. Hennessy et al.   CANCER RESEARCH

Integrin  2 Mediates Selective Metastasis to the Liver

(2009) K. Yoshimura et al.   CANCER RESEARCH

Hepatic complications of breast cancer

(2009) Jennifer R Diamond et al.   LANCET ONCOLOGY

Three-dimensional organization of fenestrae labyrinths in liver sinusoidal endothelial cells

(2009) Filip Braet et al.   LIVER INTERNATIONAL

Expression of Tight Junction Protein Claudin-4 in Basal-Like Breast Carcinomas

(2009) Janina Kulka et al.   PATHOLOGY & ONCOLOGY RESEARCH

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype

(2009) Anne A. Blanchard et al.   VIRCHOWS ARCHIV

Loss of tight junction barrier function and its role in cancer metastasis

(2008) Tracey A. Martin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Clinical Course of Breast Cancer Patients With Metastases Limited to the Liver Treated With Chemotherapy

(2008) Ozlem Er et al.   CANCER JOURNAL

Attenuation of Junctional Adhesion Molecule-A Is a Contributing Factor for Breast Cancer Cell Invasion

(2008) M. U. Naik et al.   CANCER RESEARCH

NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells

(2008) S. Mima et al.   CARCINOGENESIS

Anti-invasive and Antimetastatic Activities of Ribosomal Protein S6 Kinase 4 in Breast Cancer Cells

(2008) A. Thakur et al.   CLINICAL CANCER RESEARCH

The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer

(2008) E Wisse et al.   GENE THERAPY

Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease

(2008) T H Kim et al.   HISTOPATHOLOGY

Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer

(2008) Fiona Lanigan et al.   INTERNATIONAL JOURNAL OF CANCER

Altered gene expression in breast cancer liver metastases

(2008) Nuray Erin et al.   INTERNATIONAL JOURNAL OF CANCER

Galectin-3 Regulates Integrin α2β1-mediated Adhesion to Collagen-I and -IV

(2008) Jens Friedrichs et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

New insights into the dynamics of sinusoidal endothelial fenestrae in liver sinusoidal endothelial cells

(2008) Hiroaki Yokomori   Medical Molecular Morphology

Signaling through ShcA Is Required for Transforming Growth Factor  - and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion

(2008) J. J. Northey et al.   MOLECULAR AND CELLULAR BIOLOGY

Transforming growth factor-β1 is the predominant isoform required for breast cancer cell outgrowth in bone

(2008) A A Mourskaia et al.   ONCOGENE

Antimetastatic Integrin as Inhibitors of Snake Venoms

(2008) Felix Rosenow et al.   NEOPLASIA